Ocean Optics Launches Powerful New Spectroscopy Software

Source : Ocean Optics

OceanView’s customizable interface puts the user in control

Dunedin, FL (May 14, 2013) – Ocean Optics has released OceanView spectroscopy software, combining powerful data processing capabilities with a clear graphical user interface for use with the company’s miniature spectrometers. OceanView is highly customizable and includes a schematic view that provides a visual roadmap of data flow from spectral inputs to processed results.

OceanView displays and utilizes spectral data from Ocean Optics spectrometers with the added flexibility of integrating temperature, voltage and other input data, allowing users to capture and visualize data from multiple sources. In addition, OceanView saves and reloads previous experiments and has a persistence of settings feature that conveniently recalls acquisition parameters and file locations. Users can customize the OceanView interface once and later access those same settings without having to rebuild them with each new session.

Inspired by customer feedback across a variety of applications, OceanView delivers a high level of experimental control. Its schematic view – a flow chart with each step of the process represented – functions as both a blueprint of the data process from inputs to results and a tool to inspect and modify the process on the fly. It delivers results in the form of an answer, rather than just a simple waveform. More than 70 schematic nodes, or connection points, can be mapped in the schematic view. Other experiment control functions such as spectral splicing, interpolation and device output control are available.

To learn more about OceanView, visit www.OceanOptics.com, contact an Ocean Optics Applications Scientist at +1 727-733-2447 or info@oceanoptics.com. ###

  • <<
  • >>

Articles List

  • More than One Way to Change a Base

    More than One Way to Change a Base

    It’s easier than ever these days to clone and sequence DNA. Thanks to CRISPR/Cas and related technologies, it’s even straightforward to rewrite genomic sequences in living cells and organisms. But as powerful as it is, CRISPR, et al., cannot induce genetic rewrites in a test tube—genome editing requires cellular machinery to repair the DNA breaks the methods produce. Instead, researchers interested in mutating cloned genes on plasmids must revert to a tried-and-true method, site-directed mutagenesis. First described in the 1970s—and earning its inventor a share of the Nobel Prize in Chemistry in 1993—site-directed mutagenesis uses short oligonucleotides to introduce single base changes, as well as insertions and deletions, to DNA plasmids. Researchers can use the method to swap amino acids in expressed proteins, test clinically relevant mutations and tweak promoters. But there’s more than one way to change a base, and molecular-tools vendors have commercialized multiple strategies. Here, we review some of the more popular approaches to site-directed mutagenesis.
  • What Doesn’t Kill You … Testing for Chemical Toxicity

    What Doesn’t Kill You … Testing for Chemical Toxicity

    Understanding the effects of small molecules, compounds and chemicals on cells is the very core of drug discovery, one in which the pharmaceutical industry continues to invest billions of dollars. Yet alongside the question of whether such entities have a desired effect looms that of whether they have a toxic effect on those cells—and ultimately the tissues and organisms the cells compose. This question has equal importance to those who protect our environment and assure that our food is safe to eat. Testing chemical toxicity can take many forms, from looking for simple surrogates of death, such as the inability to exclude trypan blue, to sophisticated measures of changes in a specific cell type’s physiology. Various assays look at pathways leading to cell death, membrane integrity, depletion of energy, ability to proliferate and changes in differentiation. They are accomplished using instruments ranging from a hemocytometer and light microscope; to a Coulter counter, microplate reader or flow cytometer; to a high-content analysis solution found principally in screening cores at biotech and larger pharmaceutical companies. Screens for loss of viability are often the first line of inquiry, and only after an entity is shown to cause a decrease in survival is it then subjected to more nuanced assays [1]. Here we look at the principal means by which entities are tested for their effects on viability.

Disqus Comments